AN ACT TO AMEND SECTION 41-29-139.1, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT A PERSON WHO DELIVERS OR CAUSES THE DELIVERY OF AN ILLICIT SYNTHETIC SUBSTANCE WITH KNOWLEDGE OF THE ILLICIT SYNTHETIC SUBSTANCE COMMITS A FELONY; AND FOR RELATED PURPOSES.
Impact
The legislation is designed to deter the distribution of fatal synthetic drugs by implementing severe penalties. Its intent is to both protect the public from the dangerous effects of fentanyl and to encourage individuals to seek medical assistance during overdoses without the fear of criminal prosecution. The bill includes a provision to ensure that individuals seeking help for someone experiencing a fentanyl overdose will not be prosecuted if evidence for any charges was obtained as a result of seeking assistance. This creates an avenue for saving lives while distinguishing between drug users and those profiting from illegal activities.
Summary
Senate Bill 2318 aims to amend Section 41-29-139.1 of the Mississippi Code to address the issue of illicit synthetic substances, particularly fentanyl. The bill specifies that a person delivering or causing the delivery of an illicit synthetic substance, fully aware of its nature, commits a felony if this action results in the death of another person from its use. The proposed penalties include a mandatory prison sentence of no less than 20 years, up to life imprisonment, alongside a fine of at least $10,000. This provision aims to hold accountable those who profit from the distribution of harmful substances.
Contention
Discussion around SB2318 may reflect underlying tensions between public safety advocacy and concerns regarding the criminalization of drug users. Proponents of the bill argue that it is necessary for protecting the community and holding drug dealers accountable. However, critics may point out that increased penalties could further criminalize addiction without addressing the root causes or offering sufficient rehabilitation options. The bill's emphasis on imposing severe sentences may ignite debates regarding its effectiveness in curbing drug-related deaths versus potentially exacerbating the existing challenges in how society treats drug use and addiction.